Generated by GPT-5-mini| Nutraceutical International Corporation | |
|---|---|
| Name | Nutraceutical International Corporation |
| Type | Public |
| Founded | 1989 |
| Founder | Ken D. Herting |
| Headquarters | Allison Park, Pennsylvania, United States |
| Area served | Worldwide |
| Key people | Ken D. Herting (Chairman, CEO), Laurence S. Miger (CFO) |
| Industry | Dietary supplement industry |
| Products | Dietary supplements, vitamins, minerals, herbal products |
| Revenue | US$ (see Financial Performance) |
Nutraceutical International Corporation is an American company engaged in the development, manufacture, marketing, and sale of nutraceuticals, dietary supplements, vitamins, and related products. Headquartered in Allison Park, Pennsylvania, the company operates multiple manufacturing facilities and distribution channels across North America and sells through retail, direct response, and international distributors. It competes in a sector alongside companies such as Nature's Bounty Co., Glanbia plc, Herbalife, Google Health-adjacent wellness platforms, and retailers like Walmart and Costco Wholesale.
Founded in 1989 by Ken D. Herting, the company grew amid the broader expansion of the dietary supplement industry during the 1990s and 2000s, paralleling trends involving Herbalife and Amway in direct-response channels and retail expansions like Walgreens Boots Alliance. It expanded through acquisitions and facility development, acquiring brands and manufacturing assets similarly to consolidation moves by GNC Holdings, Inc. and Nature's Sunshine Products. Strategic growth included penetrating international markets and responding to regulatory environments influenced by legislation such as the Dietary Supplement Health and Education Act of 1994 and enforcement patterns from the U.S. Food and Drug Administration and Federal Trade Commission. The company’s trajectory mirrors distribution strategies used by firms like ChannelAdvisor partners and logistics networks exemplified by FedEx and United Parcel Service.
The corporation is led by founder Ken D. Herting as Chairman and Chief Executive Officer, with financial leadership historically including executives such as Laurence S. Miger in chief financial roles. The board and executive management interact with external advisors and auditors from major firms comparable to PricewaterhouseCoopers and Deloitte. Governance practices are influenced by standards set by market regulators like the Securities and Exchange Commission and listing requirements of the NASDAQ exchange. Institutional investors and proxy advisory firms similar to BlackRock, Vanguard Group, and Glass Lewis have appeared in ownership and governance discussions common to public companies.
Nutraceutical International Corporation markets a portfolio of vitamins, minerals, herbal formulas, and specialty products across brand families and private-label manufacturing. Its product lines serve segments analogous to offerings by Nature Made, NOW Foods, and Solgar. It supplies formulations for conditions and wellbeing topics discussed in publications similar to The New England Journal of Medicine and JAMA, and competes on channels used by Amazon (company), Walgreens Boots Alliance, and specialty retailers like The Vitamin Shoppe. Product development frequently references ingredient sourcing practices that intersect with suppliers in regions such as China, India, and Peru—locations noted for botanical raw materials used by peers like Himalaya Drug Company and Bayer AG.
The company operates multiple manufacturing facilities employing processes aligned with Good Manufacturing Practice principles and third-party certifications used across the sector, including standards from organizations like NSF International and inspectors akin to SGS S.A.. Quality control procedures echo industry practices used by companies such as Glanbia Nutritionals and contract manufacturers serving Nestlé Health Science. Supply chain management involves logistics partners like UPS and customs protocols tied to agencies such as U.S. Customs and Border Protection. Laboratory testing, stability studies, and batch recordkeeping reflect methodologies discussed in regulatory guidance from the U.S. Food and Drug Administration and the United States Pharmacopeia.
As a publicly traded company, the firm reports revenue, net income, and balance sheet metrics in filings submitted to the Securities and Exchange Commission. Its financial results exhibit sensitivity to retail channel trends exemplified by Walmart, e-commerce shifts led by Amazon (company), and macroeconomic factors tracked by institutions like the Federal Reserve. Capital allocation decisions, dividend and share-repurchase policies, and acquisition investments follow patterns observed at peers such as GNC Holdings, Inc. and GlaxoSmithKline's consumer divisions. Equity analysts covering the sector often compare performance with indices and benchmarks like the S&P 500 and NASDAQ Composite.
Like many companies in the supplement sector, the company has faced regulatory scrutiny, product liability claims, or litigation risks comparable to cases involving Herbalife, GNC, and Kellogg Company in consumer product litigation. Enforcement and advertising oversight can involve agencies such as the Federal Trade Commission and the U.S. Food and Drug Administration, while securities-related matters fall under the jurisdiction of the Securities and Exchange Commission and federal courts including the United States District Court for the Western District of Pennsylvania. Class action litigation and shareholder derivative suits follow precedents set in cases involving companies like Valeant Pharmaceuticals International and Enron for corporate governance contexts.
Category:Companies based in Pennsylvania Category:Dietary supplement companies of the United States